Lingfei Huang

427 total citations
20 papers, 294 citations indexed

About

Lingfei Huang is a scholar working on Molecular Biology, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lingfei Huang has authored 20 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lingfei Huang's work include Renal Diseases and Glomerulopathies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Circular RNAs in diseases (3 papers). Lingfei Huang is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Circular RNAs in diseases (3 papers). Lingfei Huang collaborates with scholars based in China, United States and South Korea. Lingfei Huang's co-authors include Jinhong Wu, Shanshan Chen, Liya Ye, Dongsheng Xiong, Shuangshuang Mei, Kai Wang, Luo Fang, Meifen Wang, Haidi Yang and Haiying Jia and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Cellular Physiology and Frontiers in Pharmacology.

In The Last Decade

Lingfei Huang

19 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingfei Huang China	10	154	123	38	28	27	20	294
Meredith P. Millis United States	7	173 1.1×	126 1.0×	26 0.7×	16 0.6×	4 0.1×	10	414
Annunziata Fragasso Germany	8	184 1.2×	95 0.8×	5 0.1×	21 0.8×	5 0.2×	16	353
Filippo Martino Germany	8	296 1.9×	254 2.1×	9 0.2×	14 0.5×	3 0.1×	12	450
Kyoko Miyamoto Japan	10	122 0.8×	44 0.4×	23 0.6×	35 1.3×	7 0.3×	29	530
James Shoaf United States	4	114 0.7×	12 0.1×	62 1.6×	9 0.3×	17 0.6×	4	328
Leticia Cuarental Spain	9	82 0.5×	18 0.1×	5 0.1×	17 0.6×	5 0.2×	12	240
Cameron J. McDonald Australia	15	90 0.6×	14 0.1×	2 0.1×	9 0.3×	6 0.2×	31	506
Shinya Ishiko Japan	11	195 1.3×	12 0.1×	3 0.1×	44 1.6×	3 0.1×	31	343
Zeina N. Al-Mahayri United Arab Emirates	9	52 0.3×	33 0.3×	2 0.1×	25 0.9×	3 0.1×	17	226
Chong Dong China	12	62 0.4×	24 0.2×	29 0.8×	32 1.1×	3 0.1×	40	304

Countries citing papers authored by Lingfei Huang

Since Specialization

Citations

This map shows the geographic impact of Lingfei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Huang more than expected).

Fields of papers citing papers by Lingfei Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Huang. The network helps show where Lingfei Huang may publish in the future.

Co-authorship network of co-authors of Lingfei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Huang. A scholar is included among the top collaborators of Lingfei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Huang. Lingfei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Haiyan, Hanqing Lin, Lingfei Huang, et al.. (2023). miR-34a/DRP-1-mediated mitophagy participated in cisplatin-induced ototoxicity via increasing oxidative stress. BMC Pharmacology and Toxicology. 24(1). 18 indexed citations

Huang, Lingfei, et al.. (2023). Identifying Financial Report Fraud of U.S. Listed Chinese Companies. Advances in Economics Management and Political Sciences. 4(1). 344–357. 1 indexed citations

Huang, Lingfei, Yanhong Li, Pu Wang, et al.. (2022). Integrated analysis of immune- and apoptosis-related lncRNA-miRNA-mRNA regulatory network in children with Henoch Schonlein purpura nephritis. Translational Pediatrics. 11(10). 1682–1696. 6 indexed citations

Huang, Lingfei, et al.. (2022). Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study. Frontiers in Pharmacology. 12. 726667–726667. 2 indexed citations

Wu, Yuanyuan, et al.. (2022). Prevalence and predictors of medication non-adherence in children with inflammatory bowel disease in China: A cross-sectional study. Frontiers in Pharmacology. 13. 1062728–1062728. 1 indexed citations

Gao, Peng, Junyan Wang, Liwen Zhang, et al.. (2022). The impact of ibuprofen on valproic acid plasma concentration in pediatric patients. Xenobiotica. 52(6). 535–540.

Sun, Ling, Ying Xu, & Lingfei Huang. (2021). Impact of Intraoperative Salvaged Blood Autotransfusion During Obstetric Hemorrhage on the Coagulation Function: A Retrospective Cohort Analysis. Clinical and Applied Thrombosis/Hemostasis. 27. 2975245780–2975245780. 2 indexed citations

Miao, Jing, Peng Gao, Qian Li, et al.. (2021). Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review. International Journal of Molecular Sciences. 22(20). 11227–11227. 9 indexed citations

Yang, Haidi, et al.. (2020). Repetitive transcranial magnetic stimulation on chronic tinnitus: a systematic review and meta-analysis. BMC Psychiatry. 20(1). 547–547. 30 indexed citations

10.

Zhu, Zhengyi, Peng Gao, Junyan Wang, et al.. (2020). PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database. International Journal of Clinical Pharmacology and Therapeutics. 58(6). 332–342. 3 indexed citations

11.

Wang, Huijuan, Lingfei Huang, Peng Gao, et al.. (2020). Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trial. BMJ Open. 10(2). e030738–e030738. 12 indexed citations

12.

Wang, Junyan, Lingfei Huang, Peng Gao, et al.. (2020). Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European Journal of Clinical Pharmacology. 77(1). 71–77. 11 indexed citations

13.

Wang, Huijuan, Lingfei Huang, Junyan Wang, et al.. (2020). Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(12). 1201–1209. 4 indexed citations

14.

Gao, Peng, Yan Hu, Junyan Wang, et al.. (2020). Underlying Mechanism of Insulin Resistance: A Bioinformatics Analysis Based on Validated Related-Genes from Public Disease Databases. Medical Science Monitor. 26. 5 indexed citations

15.

Chen, Xing, Dongsheng Xiong, Liya Ye, et al.. (2019). Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell International. 19(1). 45–45. 74 indexed citations

16.

Huang, Lingfei, Yixi Liu, Zheng Jiao, et al.. (2019). Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis–Menten pharmacokinetic model. European Journal of Pharmaceutical Sciences. 143. 105199–105199. 19 indexed citations

17.

Wang, Junyan, Peng Gao, Yan Hu, et al.. (2019). Evaluation of Concentration Errors and Inappropriate Dose Tailoring of Tacrolimus Caused by Sampling-Time Deviations in Pediatric Patients With Primary Nephrotic Syndrome. Therapeutic Drug Monitoring. 42(3). 392–399. 2 indexed citations

18.

Huang, Lingfei, Huifen Zhang, Zhengyi Zhu, et al.. (2019). Impact of CYP3A4/5 and ABCB1 Polymorphisms on Tacrolimus Exposure and Response in Pediatric Primary Nephrotic Syndrome. Pharmacogenomics. 20(15). 1071–1083. 16 indexed citations

19.

Chen, Xing, Dongsheng Xiong, Hui-Chun Yang, et al.. (2018). Long noncoding RNA OPA‐interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR‐143‐3p. Journal of Cellular Physiology. 234(4). 5264–5275. 43 indexed citations

20.

Zuo, Shanru, Xiao‐cong Zuo, Yang He, et al.. (2017). Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. Journal of Cancer. 9(2). 321–330. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact